Patrick Borgen, MD, built Brooklyn's breast cancer program from 47 patients to 8,000. Now he and Joshua Feinberg, MD discuss what surgery looks like next.
Joshua Feinberg, MD
Advertisement
Articles by Joshua Feinberg, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Tentative Approval to New Cabozantinib Capsule Formulation
2
Lurbinectedin Second-Line SCLC Indication to Be Withdrawn After LAGOON
3
FDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas
4
Neoadjuvant LI Improves OS in Low PD-L1–Selected Oral Cancer
5